Track topics on Twitter Track topics that are important to you
Adding a beta-lactam to standard therapy for MRSA bacteremia does not improve outcomes and appears to up the risk for kidney injury, data from a randomized controlled trial showed.
Medscape Medical News
Original Article: Drug Combo No Better in MRSA Blood Infections, Ups RiskNEXT ARTICLE
MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16 account for 96% of MRSA blood...